Pfizer wins $10 billion bidding war for Metsera as Novo Nordisk exits
Nov 8, 2025
NEW YORK/LONDON (Web News) – US drugmaker Pfizer has clinched a $10 billion deal for obesity drug developer Metsera, capping a fierce biotech bidding war between the New York-based pharma giant and Danish rival Novo Nordisk. Metsera accepted a sweetened offer from Pfizer
